Production of functional recombinant G-protein coupled receptors for heteromerization studies

Journal of Neuroscience Methods

Volumn 199, Issue 2, 2011, Pages 258-264

  Čavić, Milena ^a   Lluís, Carme ^b   Moreno, Estefanía ^b   Bakešová, Jana ^b   Canela, Enric I ^b   Navarro, Gemma ^b  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Adenosine; Cloning; Dopamine; Heteromer; Histamine; Parkinson's disease

Indexed keywords

G PROTEIN COUPLED RECEPTOR;

ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CONTROLLED STUDY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HETEROMERIZATION; HUMAN; HUMAN CELL; NIGRONEOSTRIATAL SYSTEM; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ANIMALS; BACTERIAL PROTEINS; CHO CELLS; CRICETINAE; CRICETULUS; DOPAMINE AGONISTS; DRUG DESIGN; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; LUMINESCENT PROTEINS; PARKINSON DISEASE; PROTEIN MULTIMERIZATION; RECEPTOR, ADENOSINE A2A; RECEPTORS, DOPAMINE D2; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE H3; RECOMBINANT FUSION PROTEINS;

EID: 79960236585     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2011.05.021     Document Type: Article

References (12)

1. Bulenger S., Marullo S., Bouvier M. Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol. Sci. 2005, 26:131-137.
2. Canals M., Marcellino D., Fanelli F., Ciruela F., de Benedetti P., Goldberg S.R., et al. Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J. Biol. Chem. 2003, 278:46741-46749.
3. Carriba P., Navarro G., Ciruela F., Ferré S., Casadó V., Agnati L., et al. Detection of heteromerization of more than two proteins by sequential BRET-FRET. Nat. Methods 2008, 8:727-733.
4. Ferrada C., Ferré S., Casadó V., Cortés A., Justinova Z., Barnes C., et al. Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function. Neuropharmacology 2008, 55:190-197.
5. Ferre S., Ciruela F., Quiroz C., Lujan R., Popoli P., Cunha R.A., et al. Adenosine receptor heteromers and their integrative role in striatal function. ScientificWorldJournal 2007, 7(S2):74-85.
6. Franco R., Casado V., Cortes A., Ferrada C., Mallol J., Woods A., et al. Basic concepts in G-protein-coupled receptor homo- and heterodimerization. ScientificWorldJournal 2007, 7(S2):48-57.
7. Franco R. Neurotransmitter receptor heteromers in neurodegenerative diseases and neural plasticity. J. Neural Transm. 2009, 116:983-987.
8. Fuxe K., Marcellino D., Guidolin D., Woods A.S., Agnati L.F. Heterodimers and receptor mosaics of different types of G-protein-coupled receptors. Physiology 2008, 23:322-332.
9. Gilchrist A. GPCR molecular pharmacology and drug targeting: shifting paradigms and new directions 2010, John Wiley & Sons, Inc., Hoboken, NJ, p. 191.
10. Leurs R., Bakker R.A., Timmerman H., de Esch I.J. The histamine H3 receptor: from gene cloning to H3 receptor drugs. Nat. Rev. Drug Discov. 2005, 4:107-120.
11. Moreno E., Hoffmann H., Gonzalez-Sepúlveda M., Navarro G., Casadó V., Cortés A., et al. Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway. J. Biol. Chem. 2011, 286:5846-5854.
12. Panetta R., Greenwood M.T. Physiological relevance of GPCR oligomerization and its impact on drug discovery. Drug Discov. Today 2008, 13:1059-1066.